The role of growth factors in the malignant and invasive progression of intrinsic brain tumours

Anticancer Research

Volumn 17, Issue 6 B, 1997, Pages 4163-4172

  Finn, Paula E ^a   Bjerkvig, Rolf ^b   Pilkington, Geoffrey J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Brain tumour; Growth factor; Invasion

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; BRAIN TUMOR; CANCER INVASION; CELL PROLIFERATION; GLIOMA; HUMAN; MALIGNANT TRANSFORMATION; MITOGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TUMOR VASCULARIZATION;

ANIMALS; BRAIN NEOPLASMS; CELL DIVISION; CELL MOVEMENT; DISEASE PROGRESSION; GANGLIOSIDES; GROWTH SUBSTANCES; HUMANS; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; TRANSFORMATION, GENETIC;

EID: 0031458424     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Cross M and Dexter TM: Growth factors in development, transformation and tumourigenesis. Cell 64: 271-280, 1991.
2. Heldin C-H and Westermark B: Growth factors as transforming proteins. Eur J Biochem 184: 487-496, 1989.
3. Ross R, Raines EW and Bowen-Pope DF: The biology of platelet-derived growth factor. Cell 46: 155-169, 1987.
4. Heldin C-H, Johnsson A, Wennergren S, Wernstedt C, Betsholtz C and Westermark B: A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains. Nature 319: 511 -514, 1986.
5. Hammacher A, Hellman U, Johnsson A, Östman A, Gunnarsson K, Westermark B, Wasteson A and Heldin C-H: A major part of platelet-derived growth factor purified from human platelets is a heterodimer of one A and one B chain. J Biol Chem 263: 16493-16498, 1988.
6. Stroobant P and Waterfield MD: Purification and properties of porcine platelet-derived growth factor. EMBO J 3: 2963-2967, 1984.
7. Nister M, Hammacher A, Mellström K, Siegbahn A, Rönnstrand L, Westermark B and Heldin C-H: A glioma-derived PDGF A chain homodimer has different functional activities from a PDGF AB heterodimer purified from human platelets. Cell 52: 791-799, 1988.
8. Pringle N, Collarini EJ, Mosley MJ, Heldin C-H, Westermark B and Richardson WD: PDGF A chain homodimers drive proliferation of bipotential (0-2A) glial progenitor cells in the developing rat optic nerve. EMBO J 4: 1049-1056,1989.
9. Massagué J: Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells. J Biol Chem 258: 13614-13620, 1983
10. Robens AB, Anzano MA, Lamb LC, Smith JM, Frolik CA, Marquardt H, Todaro GJ and Sporn MB: Isolation from murine sarcoma cells of novel transforming growth factors potentiated by EGF. Nature 295: 417-419, 1982.
11. Todaro GJ, Fryling C and DeLarco JE: Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factors. Proc Natl Acad Sci USA 77: 5258-5262, 1980.
12. Reynolds FH Jr, Todaro GJ, Fryling C and Stephenson JR: Human transforming growth factors induce tyrosin phosphorylation of EGF receptors. Nature 292: 259-262, 1981.
13. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD and Seeburg PH: Human epidermal growth factor receptor cDNA sequence and abberant expression of the amplified gene in A431 cells. Nature 309: 418-425, 1984.
14. Gospodarowicz D, Neufeld G, and Schweigerer L: Fibroblast growth factor. Mol Cell Endocrinol 46: 187-204, 1986.
15. Froesch ER, Schmid C, Schwander J and Zapf J: Actions of insulin-like growth factors. Annu Rev Physiol 47: 443-467, 1985.
16. Zapf J, Schmid C and Froesch ER: Biological and immunological properties of insulinlike growth factors (IGF), I and II. Clin Endocrinol Metab 13: 3-30, 1984.
17. Froesch ER, Schmid C, Schwander J and Zapf J: Actions of insulin-like growth factors. Annu Rev Physiol 47: 443-467, 1985
18. McMorris FA, Smith TM, DeSalvo S and Furlanetto RW: Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development. Proc Natl Acad Sci USA 83: 822-826, 1986.
19. Rechler MM and Nissley SP: The nature and regulation of the receptors for insulin-like growth factors. Annu Rev Physiol 47: 425-442, 1985.
20. Zapf J, Schoenle E and Froesch ER: Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum. Eur J Biochem 87: 285-296, 1978.
21. Ferrara N, Houck KA, Jakeman LB, Winer J and Leung DW: The vascular endothelial growth-factor family of polypeptides. J Cell Biochem 47: 211-218, 1991.
22. Breier G, Albrecht U, Sterrer S and Risau W: Expression of vascular endothelial growthfactor during embryonic angiogenesis and endothelial cell differentiation. Development 114: 521-532, 1992.
23. Conn G, Sodermann DD, Schaeffer MT, Wile M, Hatcher VB and Thomas KA:Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci 87: 1323-1327, 1990.
24. Weindel K, Marmé D and Weich H:Aids-associated Kaposis-Sarcoma cells in culture express vascular endothelial growth factor. Biochem Biophys Res Commun 183: 1167-1174, 1992.
25. Leung DW, Cachianes G, Kuang W-J, Goeddel DV and Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989.
26. Jakeman LB, Winer J, Bennett GL, Altar CA and Ferrara N: Binding-sites for vascular endothelial growth factor during embryogeni'c angiogenesis and endothelial-cell differentiation. J Clin Invest 89: 244-253, 1992
27. 1 on collagen synthesis, integrin expression, adhesion and invasion of glioma cells. J Neuropath Exp Neurol 54: 36-244, 1995.
28. Gentry LE, Lioubin, MN, Purchio AF and Marquardt H: Molecular events in the processing of recombinant type I pre-pro-transforming growth factor-beta to the mature polypeptide. Mol Cell Biol 8: 162-8, 1988.
29. Hunter T and Cooper JA:Protein-tyrosine kinases. Annu Rev Biochem 54: 897-930, 1985.
30. Besmer P, Snyder HW Jr, Murphy JE, Hardy WG Jr and Parodi A:The Parodi-Irgens feline sarcoma virus and simian sarcoma virus have homologous oncogenes, but in different contexts of the viral genomes. J Virol 46: 603-613, 1983.
31. Josephs SF, Ratner L, Clarke MF, Westin EH, Reitz MS and Wong-Staal F: Transforming potential of human c-sis nucleotide sequences encoding platelet derived growth factor. Science 225: 636-639, 1984.
32. Bejcek BE, Li DY and Deuel TF: Transformation by c-sis occurs by an internal autoactivation mechanism.Science 245: 1496-1499, 1989.
33. Burgess WH and Maciag, T: The heparin-binding (fibroblast) family of proteins. Annu Rev Biochem 58: 575-606, 1989.
34. Geissler EN, Ryan MA and Housman DE: The dominant white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 55: 185-192, 1988.
35. Yen HJ, Pierce GF and Deuel TF: Ultrastructural localization of platelet-derived growth factor/v-sis-related protein(s) in cytoplasm and nucleus of simian sarcoma virus-transformed cells. Proc Natl Acad Sci USA 84: 2317-2321, 1987.
36. Redekop GJ and Naus CCG: Transfection with bFGF sense and antisense cDNA resulting in modification of malignant glioma growth. JNeurosurg 82: 83-90, 1995.
37. Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG and Vertosick FT: Response of low-passage human malignant gliomas in vitro to stimulation and selective inhibition of growth factor-mediated pathways. JNeurosurg 75: 284-293, 1991.
38. Frappaz D, Singletary SE, Spitzer G and Yung A: Enhancement of growth of primary metastatic fresh human tumors of the nervous system by epidermal growth factor in serumfree short term culture. Neurosurgery 23: 355-359, 1988.
39. Westphal M, Brunken M, Rohde E and Herrmann HD:Grrowth factors in cultured human glioma cells: differential efffects of FGF, EGF and PDGF. Cancer Letters 38: 283-296, 1988.
40. Kuratsu J and Ushio Y: Antitumour effect of trapidil, an antagonist of PDGF on glioma. JNeurooncol 7 (Suppl 1) 17 (abstract), 1989.
41. Ohnishi H, Yamaguchi K, Shimada S, Susuki Y and Kumagai A: A new approach to the treatment of arterosclerosis and trapidil as an antagonist to platelet-derived growth factor. Life Sci 28: 1641-1646, 1981
42. Richardson WD, Pringle N, Mosley MJ, Westermark B and Duboisdalco M: A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 53: 309-319, 1988
43. Samuels V, Barrett JM, Bockman S, Pantazis CG and Alien MB Jr: Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas. Am J Pathol 134: 895-902, 1989.
44. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR and Vogelstein B: Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84: 6899-6903, 1987
45. Westphal M, Brunken M, Rohde E and Hermann HD: Growth factors in cultured human glioma cells:differential effects of FGF, EGF and PDGF. Cancer Lett 38: 283-296, 1988
46. Davies RL, Grosse VA, Kucherlapati R and Bothwell M: Genetic analysis of epidermal growth factor action: assignment of human epidermal growth factor receptor gene to chromosome 7. Proc Natl Acad Sci USA 77: 4188-4192, 1980.
47. Kawamoto T, Mendelsohn J, Le A, Sato GH, Lozar CS and Gill GN: Relation of epidermal growth factor receptor concentration to growth of human epidermoid carcinoma A431 cells. J Biol Chem 259: 7761-7766, 1984.
48. Coffey RJ Jr, Derynck R, Wilcox JN, Bringman TS, Goustin AS, Moses HL and Pittelkow MR: Production and auto-induction of transforming growth factor (alpha) in human keratinocytes. Nature 328: 817-820, 1987.
49. Clark AJ, Ishii S, Richert N, Merlino GT and Pastan I: Epidermal growth factor regulates the expression of its own receptor. Proc Natl Acad Sci USA 82: 8374-8378, 1985.
50. Maruno M, Kovach JS, Kelly PJ and Yanagihara T: Transforming growth factor-α, epidermal growth factor receptor, and proliferating potential in benign and malignant gliomas. J Neurosurg 75: 97-102, 1991.
51. Paulsson Y, Hammacher A, Heldin CH: Possible positive autocrine feedback in the prereplicative phase of human fibroblasts. Nature 328: 715-717, 1987.
52. Sporn MB and Todaro GJ: Autocrine secretion and malignant transformation of cells. N Eng J Med 303: 878-880, 1980.
53. Stefanik DF, Rizkalla LR, Soi A, Goldblatt SA and Rizkalla WM: Acidic and basic fibroblast growth factors are present in glioblastoma multiforme. Cancer Res 51: 5760-5765, 1991.
54. Takahashi JA, Fukumoto M, Kozai Y, Ito N, Oda Y, Kikuchi H and Hatanaka M: Inhibition of cell growth and tumorigenesis of human glioblastoma cells by a neutralizing antibody against human basic fibroblast growth factor. FEBS Lett 288: 65-71, 1991.
55. Takahashi JA, Suzui H, Yasuda Y, Ito N, Ohta M, Jaye M, Fukumoto M, Oda Y, Kikuchi H and Hatanaka M: Gene expression of fibroblast growth factor receptors in the tissue of human gliomas and meningiomas. Biochem Biophys Res Commun 171: 1-7, 1991.
56. Glisson SN, El-Etr AA and Lim R: Prolongation of pancuronium-induced neuromuscular blockade by intravenous infusion of nitroglycerin. Anaesthesiology 57: 127-130, 1979.
57. Michenfleder JD and Tinker JH: Cyanide toxicity and thiosulfate protection during chronic administration of sodium nitropruside in the dogs: correlation with a human case. Anesthesiology 47: 441-448, 1977.
58. Bumstock G: Purinergic nerves. Pharmaco Rev 204: 317-322, 1972
59. Walicke PA: Basic and acidic fibroblast growth factors have trophic effects on neurons from multiple CNS regions. J Neurosci 8: 2618-2627, 1988.
60. Morrison RS, Gross JL, Herblin WF, Reilly TM, Lasala PA, Alterman RL, Moskal JR, Kornblith PL and Dexter DL: Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line. Cancer Res 50: 2524-2529, 1990
61. Paulus W, Grothe C, Sensenbrenner M, Janet T, Baur I, Graf M and Roggendorf W: Localization of basic fibroblast growth factor, a mitogen and angiogenic factor in human brain tumours. Acta Neuropathol 79: 418-423, 1990.
62. Takahashi JA, Mori H, Fukumoto M, Igarashi K, Jaye M, Oda Y, Kikuchi H and Hatanaka M: Gene expression of fibroblast growth factor in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc Natl Acad Sci USA 87: 5710-5714, 1990.
63. Takahashi JA, Fukumoto M, Igarishi K, Oda Y, Kikuchi H and Hatanaka M: Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J Neurosurg 76: 792-798, 1992.
64. Pilkington GJ, Dunan JR, Rogers JPL Clarke TM and Knott JCM: Growth factor modulation of surface ganglioside expression in cloned neoplastic glia. Neurosci Lett 186: 53-56, 1993.
65. Grunberger G, Lowe WL Jr, McElduff A and Glick RP: Insulin receptor of human cerebral gliomas. Structure and function. J Clin Invest 77: 997-1005, 1986
66. Sandberg AC, Engberg C and Lake M: The expression of insulin-like growth factor I and insulin-like growth factor II genes in the human fetal and adult brain and in gliomas. Neurosci Lett 93: 114-119, 1988.
67. Lichtor T, Kurpakus MA and Gurney ME: Differential expression of insulin-like growth factor II in human meningiomas. Neurosurgery 29: 405-410, 1991.
68. Glick RP, Unterman TG, Van der Woude M and Zollner Blaydes L: Insulin and insulinlike growth factors in central nervous system tumors: Part V: Production of insulin-like growth factors I and II in vitro. J Neurosurg 77: 445-450, 1992.
69. Merzak A, Koochekpour S, Dkhissi F, Raynal S, Lawrence D and Pilkington GJ: Synergism between growth factors in the control of glioma cell proliferation, migration and invasion in vitro. Int J Oncol 6: 1079-1085
70. 1 modulates the effects of basic fibroblast growth factor on growth and phenotypic expression of rat astroblasts in vitro. J Cell Physiol 144: 473-484, 1990.
71. Pilkington GJ: Tumour cell migration in the central nervous system. Brain Pathology 4: 157-166, 1994.
72. McKeever PE, Davenport RD and Shakui P: Patterns of antigenic expression of human glioma cells. Crit Rev Neurobiol 6: 119-147, 1991.
73. Liotta LA: Tumor invasion and metastases-role of the extracellular matrix. Rhoads Memorial Award Lecture Cancer Res 46: 1-7, 1986.
74. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodelling. Trends Genet 6: 121-125, 1990.
75. Howard EW and Banda MJ: Binding of tissue inhibitor of metalloproteinases-2 to distinct sites on human 72 kDa gelatinase: Identification of a stabilization site. J Biol Chem 260: 17972-17977, 1991.
76. Matrisian LM and Hogan BLM: Growth factor-regulated proteases and extracellular matrix remodelling during mammalian development. Curr Topics Dev Biol 24: 219-259, 1991.
77. Overall CM, Wrana JL and Sodek J: Independent regulation of collagenase, 72-kDa progelatinase and metalloproteinase inhibitor expression in human fibroblasts by transforming growth factor-ß. J Biol Chem 264: 1860-1869, 1988.
78. Pavelic K, Despot N, Levanat S and Casl T: Protective role of transforming growth ß factor (TGF-B) in tumor-induced degradation of basement membranes. Biol Chem Hoppe-Seyler 371: 687-692, 1990.
79. Nakano A, Tani A, Miyazaki K, Yamamoto Y, Furyama J: Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83: 298-307, 1995.
80. Svennerholm L: Chromatographic separation of human brain gangliosides. J Neurochem 10: 613-623, 1963.
81. Yavin E, Gabai A and Gil S: Nerve growth factor mediates monosialogangliosides-induced release of fibronectin and J1/tenascin from C6 glioma cells. J Neurochem 56: 105-112, 1991.
82. Merzak A, Koochekpour S and Pilkington GJ: Cell surface gangliosides are involved in the control of glioma cell invasion in vitro. Neurosci Lett 777: 44-46, 1994.
83. Drago J, Reid KL and Bartlett PF: Induction of the ganglioside marker A2BS on cultured cerebellar neural cells by growth factors. Neurosci Lett 707: 245-250, 1989.
84. Koochekpour S, Merzak A and Pilkington GJ: Growth factors and gangliosides stimulate laminin production by human glioma cells in vitro. Neurosci Lett 186: 53-56, 1995.
85. Engebraaten O, Bjerkvig R, Pedersen PH and Laerum OD: Effects of EGF, bFGF, NGF and PDGF (bb) on cell proliferative, migratory and invasive capacities of human brain tumour biopsies in vitro. Int J Cancer 53: 209-214, 1993.
86. Lund-Johansen M, Forsberg K, Bjerkvig R and Laerum OD: Effects of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture. Acta Neuropathol 84: 190-197, 1992.
87. Nister M, Heldin CH. Wasteson Å Westermark B: Clonal variation in the production of a platelet-derived growth factor protein and corresponding receptors in a human malignant glioma. Ann NY Acad Sci 397: 25-33, 1982.
88. Merzak A, McCrea S, Koochekpour S and Pilkington GJ: Control of human gliioma cell growth, migration and invasion in vitro by transforming growth factor beta 1. Br J Cancer 70: 199-203, 1994.
89. Paulus W and Tonn JC: Basement membrane invasion of glioma cells mediated by integrin receptors. J Neurosurg 80: 515-519, 1994.
90. Nabi IV, Watanabe H, Silletti S and Raz A: Tumor cell autocrine motility factor receptor. In: Cell Motility Factors (as above), 1991.
91. Schor SL, Grey AM, Picardo M, Schor A, Howell A, Ellis I and Rushtoh G: Heterogeneity amongst fibroblasts in the production of migration stimulating factor (MSF): Implications for cancer pathogenesis. In: Cell Motility Factors (as above), 1991.
92. Gherardi E and Coffer A: Purification and characterisation of scatter facter. In: Cell Motility Factors (as above), 1991.
93. Ohnishi T, Arita N, Hayakawa T, Izumoto S Yamamoto H: Motility factor produced by malignant glioma cells: Role in tumor invasion. J Neurosurg 73: 881-888, 1990.
94. Weidner N, Semple JP, Welch WR and Folkman J: Tumor angiogenesis and metastasis correlation in invasive breast-carcinoma. New Engl J Med 324: 1-8, 1991.
95. Folkman J and Klagsbrun M: Angiogenic factors. Science 235: 442-447, 1987.
96. Bouck N: Tumor angiogenesis: the role of oncogenes and tumor suppressor genes. Cancer Cells 2: 179-185, 1990.
97. Folkman J: What is the evidence that tumors are angiogenesis-dependent? [Editorial] J Natn Cancer Inst 82: 4-6, 1990.
98. Plate KH, Breier G, Farrell C and Risau W: Platelet-derived growth factor receptor-beta is induced during tumor development and up-regulated during tumor progression in endothelial cells in human gliomas. Lab Invest 67: 529-534, 1992.
99. Plate KH, Breier G, Weich HA and Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis tactor in human gliomas in vivo. Nature 359: 845-847, 1992.